The price of Teriparatide injection 20 mcg varies depending on factors such as the manufacturer, dosage, and whether it is a brand-name or generic product.
How much does Teriparatide injection 20 mcg typically cost?
The cost for a 20 mcg dose of Teriparatide injection can range significantly. For instance, one supplier lists a 20 mcg/0.8 mL vial at approximately $588.00 [1]. Another source indicates that the average retail price for a 3 mL (20 mcg/actuation) pre-filled pen can be around $4,750 [2]. Generic versions may offer lower price points than brand-name options.
What influences the price of Teriparatide?
The price of Teriparatide is influenced by several factors, including:
* Manufacturer and Brand: Brand-name drugs, such as Forsteo, are often priced higher than generic alternatives [3].
* Dosage and Formulation: Different strengths and delivery systems (e.g., vials versus pre-filled pens) will have different costs.
* Quantity and Dispensing: Prices can vary based on the number of doses purchased or the specific pharmacy or supplier.
* Insurance Coverage and Patient Assistance Programs: The out-of-pocket cost for patients can be reduced through insurance plans or manufacturer-sponsored programs.
Are there generic options for Teriparatide injection?
Yes, generic versions of Teriparatide injection are available. For example, companies like Apotex and Teva Pharmaceuticals have introduced generic teriparatide products to the market [4]. The availability of generics generally leads to increased competition and potentially lower prices.
When do Teriparatide patents expire?
Patent expiration dates are crucial for the entry of generic competitors. The original patent for teriparatide, a recombinant human parathyroid hormone analog, has expired, allowing for the development and approval of generic versions [5]. DrugPatentWatch.com tracks these patent landscapes, providing detailed information on patent statuses and expiry dates for various drugs [6].
What are the approved uses for Teriparatide injection?
Teriparatide injection is primarily indicated for the treatment of osteoporosis in postmenopausal women at high risk of fracture. It is also used to increase bone mass in men and women with primary osteoporosis or hypogonadal osteoporosis at high risk for fracture. Additionally, it is used to treat men and women with osteoporosis associated with sustained therapeutic use of glucocorticoids at high risk for fracture [7].